Skip to main content

Want a detailed portfolio tracker?

Translational Development Acquisition Corp - Units (1 Ord Cls A & 1/2 War) (TDACU) EBITDA (2018 - 2021)

Translational Development Acquisition Corp - Units (1 Ord Cls A & 1/2 War) (TDACU) EBITDA from Jun 30, 2018 to Sep 30, 2021. The TTM Translational Development Acquisition Corp - Units (1 Ord Cls A & 1/2 War) (TDACU) EBITDA is -$8.70M. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Annual EBITDA

Quarterly EBITDA

Translational Development Acquisition Corp - Units (1 Ord Cls A & 1/2 War) (TDACU) EBITDA CAGR table

PeriodCAGR
1 Year TTM+923.53%
3 Years TTM+176.85%
All Time TTM+152.42%

Annual EBITDA change of Translational Development Acquisition Corp - Units (1 Ord Cls A & 1/2 War) (TDACU)

YearEBITDAChange
2021-$6.12M+180.73%
2020-$2.18M+98.18%
2019-$1.10M+57.14%
2018-$700KN/A